Related Experiment Video
Updated: Jun 23, 2026

Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
Decreased DNA methyltransferase levels contribute to abnormal gene expression in "senescent" CD4(+)CD28(-) T cells
Ying Liu1, Yingxuan Chen, Bruce Richardson
1Department of Medicine, University of Michigan, USA.
Abstract:
A senescent CD4(+)CD28(-) T cell subset develops with aging and in chronic inflammatory diseases like rheumatoid arthritis, and is implicated in plaque rupture and myocardial infarctions. This subset is pro-inflammatory, cytotoxic for endothelial cells, and aberrantly expresses genes like CD70, perforin and killer cell immunoglobulin-like receptor (KIR) genes. Why CD4(+)CD28(-) cells overexpress these genes is unclear. We found that the CD70, perforin and KIR2DL4 promoters are demethylated in CD4(+)CD28(-) T cells, and that DNA methyltransferase 1 (Dnmt1) and Dnmt3a levels are decreased in this subset. siRNA "knockdown" of Dnmt1, but not Dnmt3a, in CD4(+)CD28(+) T cells caused similar demethylation and overexpression of KIR2DL4, perforin and CD70, while simultaneous knockdown of Dnmt1 and Dnmt3a caused greater demethylation and overexpression of these genes than Dnmt1 alone. We conclude that decreased Dnmt1 and Dnmt3a cause demethylation and overexpression of these and perhaps other genes in CD4(+)CD28(-) cells, potentially contributing to pathologic functions by this subset.
Insights
Aging and inflammation promote a harmful T cell subset (CD4(+)CD28(-)) that overexpresses specific genes. Decreased DNA methyltransferase enzymes (Dnmt1 and Dnmt3a) cause gene demethylation and overexpression, contributing to disease.
Area of Science:
- Immunology
- Molecular Biology
- Epigenetics
Background:
- Senescent CD4(+)CD28(-) T cells accumulate with aging and in chronic inflammatory diseases.
- This T cell subset is linked to cardiovascular events and exhibits pro-inflammatory and cytotoxic properties.
- Aberrant gene expression, including CD70, perforin, and killer cell immunoglobulin-like receptor (KIR) genes, is characteristic of CD4(+)CD28(-) T cells.
Purpose of the Study:
- To investigate the mechanisms underlying the overexpression of specific genes in CD4(+)CD28(-) T cells.
- To determine the role of DNA methylation and DNA methyltransferases in regulating gene expression in this T cell subset.
Main Methods:
- Analysis of DNA methylation status at CD70, perforin, and KIR2DL4 gene promoters in CD4(+)CD28(-) and CD4(+)CD28(+) T cells.
- Quantification of DNA methyltransferase 1 (Dnmt1) and Dnmt3a levels in these T cell subsets.
- siRNA-mediated knockdown of Dnmt1 and Dnmt3a in CD4(+)CD28(+) T cells to assess their functional impact on gene expression and promoter methylation.
Main Results:
- CD70, perforin, and KIR2DL4 promoters were found to be demethylated in CD4(+)CD28(-) T cells.
- Levels of DNA methyltransferase 1 (Dnmt1) and Dnmt3a were decreased in the CD4(+)CD28(-) T cell subset.
- Dnmt1 knockdown in CD4(+)CD28(+) T cells mimicked the demethylation and overexpression of target genes observed in CD4(+)CD28(-) cells.
- Combined knockdown of Dnmt1 and Dnmt3a resulted in more pronounced demethylation and gene overexpression than Dnmt1 knockdown alone.
Conclusions:
- Reduced expression of Dnmt1 and Dnmt3a contributes to the demethylation and subsequent overexpression of CD70, perforin, and KIR2DL4 genes in CD4(+)CD28(-) T cells.
- These epigenetic alterations may underlie the pathogenic functions associated with the CD4(+)CD28(-) T cell subset.
- Targeting DNA methylation pathways could offer therapeutic strategies for diseases associated with CD4(+)CD28(-) T cells.
Related Concept Videos
Abnormal Proliferation
Replicative Cell Senescence
Replicative Cell Senescence
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Inhibition of Cdk Activity
